Cargando…

Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia

BACKGROUND: Trachoma is the leading infectious cause of blindness worldwide. In communities where the district level prevalence of trachomatous inflammation-follicular among children ages 1–9 years is ≥5%, WHO recommends annual mass drug administration (MDA) of antibiotics with the aim of at least 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Astale, Tigist, Sata, Eshetu, Zerihun, Mulat, Nute, Andrew W., Stewart, Aisha E. P., Gessese, Demelash, Ayenew, Gedefaw, Melak, Berhanu, Chanyalew, Melsew, Tadesse, Zerihun, Callahan, E. Kelly, Nash, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833287/
https://www.ncbi.nlm.nih.gov/pubmed/29451881
http://dx.doi.org/10.1371/journal.pntd.0006270
_version_ 1783303458011480064
author Astale, Tigist
Sata, Eshetu
Zerihun, Mulat
Nute, Andrew W.
Stewart, Aisha E. P.
Gessese, Demelash
Ayenew, Gedefaw
Melak, Berhanu
Chanyalew, Melsew
Tadesse, Zerihun
Callahan, E. Kelly
Nash, Scott D.
author_facet Astale, Tigist
Sata, Eshetu
Zerihun, Mulat
Nute, Andrew W.
Stewart, Aisha E. P.
Gessese, Demelash
Ayenew, Gedefaw
Melak, Berhanu
Chanyalew, Melsew
Tadesse, Zerihun
Callahan, E. Kelly
Nash, Scott D.
author_sort Astale, Tigist
collection PubMed
description BACKGROUND: Trachoma is the leading infectious cause of blindness worldwide. In communities where the district level prevalence of trachomatous inflammation-follicular among children ages 1–9 years is ≥5%, WHO recommends annual mass drug administration (MDA) of antibiotics with the aim of at least 80% coverage. Population-based post-MDA coverage surveys are essential to understand the effectiveness of MDA programs, yet published reports from trachoma programs are rare. METHODS: In the Amhara region of Ethiopia, a population-based MDA coverage survey was conducted 3 weeks following the 2016 MDA to estimate the zonal prevalence of self-reported drug coverage in all 10 administrative zones. Survey households were selected using a multi-stage cluster random sampling design and all individuals in selected households were presented with a drug sample and asked about taking the drug during the campaign. Zonal estimates were weighted and confidence intervals were calculated using survey procedures. Self-reported drug coverage was then compared with regional reported administrative coverage. RESULTS: Region-wide, 24,248 individuals were enumerated, of which, 20,942 (86.4%) individuals were present. The regional self-reported antibiotic coverage was 76.8% (95%Confidence Interval (CI):69.3–82.9%) in the population overall and 77.4% (95%CI = 65.7–85.9%) among children ages 1–9 years old. Zonal coverage ranged from 67.8% to 90.2%. Five out of 10 zones achieved a coverage >80%. In all zones, the reported administrative coverage was greater than 90% and was considerably higher than self-reported MDA coverage. Main reasons reported for MDA campaign non-attendance included being physically unable to get to MDA site (22.5%), traveling (20.6%), and not knowing about the campaign (21.0%). MDA refusal was low (2.8%) in this population. CONCLUSIONS: Although self-reported MDA coverage in Amhara was greater than 80% in some zones, programmatic improvements are warranted throughout Amhara to achieve higher coverage. These results will be used to enhance community mobilization and improve training for MDA distributors and supervisors to improve coverage in future MDAs.
format Online
Article
Text
id pubmed-5833287
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-58332872018-03-23 Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia Astale, Tigist Sata, Eshetu Zerihun, Mulat Nute, Andrew W. Stewart, Aisha E. P. Gessese, Demelash Ayenew, Gedefaw Melak, Berhanu Chanyalew, Melsew Tadesse, Zerihun Callahan, E. Kelly Nash, Scott D. PLoS Negl Trop Dis Research Article BACKGROUND: Trachoma is the leading infectious cause of blindness worldwide. In communities where the district level prevalence of trachomatous inflammation-follicular among children ages 1–9 years is ≥5%, WHO recommends annual mass drug administration (MDA) of antibiotics with the aim of at least 80% coverage. Population-based post-MDA coverage surveys are essential to understand the effectiveness of MDA programs, yet published reports from trachoma programs are rare. METHODS: In the Amhara region of Ethiopia, a population-based MDA coverage survey was conducted 3 weeks following the 2016 MDA to estimate the zonal prevalence of self-reported drug coverage in all 10 administrative zones. Survey households were selected using a multi-stage cluster random sampling design and all individuals in selected households were presented with a drug sample and asked about taking the drug during the campaign. Zonal estimates were weighted and confidence intervals were calculated using survey procedures. Self-reported drug coverage was then compared with regional reported administrative coverage. RESULTS: Region-wide, 24,248 individuals were enumerated, of which, 20,942 (86.4%) individuals were present. The regional self-reported antibiotic coverage was 76.8% (95%Confidence Interval (CI):69.3–82.9%) in the population overall and 77.4% (95%CI = 65.7–85.9%) among children ages 1–9 years old. Zonal coverage ranged from 67.8% to 90.2%. Five out of 10 zones achieved a coverage >80%. In all zones, the reported administrative coverage was greater than 90% and was considerably higher than self-reported MDA coverage. Main reasons reported for MDA campaign non-attendance included being physically unable to get to MDA site (22.5%), traveling (20.6%), and not knowing about the campaign (21.0%). MDA refusal was low (2.8%) in this population. CONCLUSIONS: Although self-reported MDA coverage in Amhara was greater than 80% in some zones, programmatic improvements are warranted throughout Amhara to achieve higher coverage. These results will be used to enhance community mobilization and improve training for MDA distributors and supervisors to improve coverage in future MDAs. Public Library of Science 2018-02-16 /pmc/articles/PMC5833287/ /pubmed/29451881 http://dx.doi.org/10.1371/journal.pntd.0006270 Text en © 2018 Astale et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Astale, Tigist
Sata, Eshetu
Zerihun, Mulat
Nute, Andrew W.
Stewart, Aisha E. P.
Gessese, Demelash
Ayenew, Gedefaw
Melak, Berhanu
Chanyalew, Melsew
Tadesse, Zerihun
Callahan, E. Kelly
Nash, Scott D.
Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia
title Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia
title_full Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia
title_fullStr Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia
title_full_unstemmed Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia
title_short Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia
title_sort population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in amhara, ethiopia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833287/
https://www.ncbi.nlm.nih.gov/pubmed/29451881
http://dx.doi.org/10.1371/journal.pntd.0006270
work_keys_str_mv AT astaletigist populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia
AT sataeshetu populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia
AT zerihunmulat populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia
AT nuteandreww populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia
AT stewartaishaep populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia
AT gessesedemelash populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia
AT ayenewgedefaw populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia
AT melakberhanu populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia
AT chanyalewmelsew populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia
AT tadessezerihun populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia
AT callahanekelly populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia
AT nashscottd populationbasedcoveragesurveyresultsfollowingthemassdrugadministrationofazithromycinforthetreatmentoftrachomainamharaethiopia